Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.62 |
| ▸ | FAAH | O00519 | 4/20 | 0.61 |
| ▸ | CNR1 | P21554 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.60 |
| ▸ | CASP2 | P42575 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5418052 | 1.00 | NAAA (0.62) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL9633191 | 1.00 | NAAA (0.62) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL21170565 | 1.00 | NAAA (0.62) | NAAASELPFAAHCNR1ALDH1A1 | |
| Propionic Acid SCHEMBL28674969 | 0.94 | SELP (0.56) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL10038806 | 0.93 | NAAA (0.62) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL9633843 | 0.93 | NAAA (0.56) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL15463170 | 0.93 | FAAH (0.69) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL21682798 | 0.93 | FAAH (0.69) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL19513937 | 0.93 | FAAH (0.69) | NAAASELPFAAHCNR1ALDH1A1 | |
| SCHEMBL20801622 | 0.93 | FAAH (0.69) | NAAASELPFAAHCNR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5869712-A | α-amino-substituted acetic acids or acid salts and their use in cosmetics | RHONE-POULENC CHIMIE (FR) | 1999-02-09 | — | — | US | claimed |
| EP-0674616-B1 | ALPHA-AMINO-SUBSTITUTED ACETIC ACID SALTS OR ACIDS AND COSMETIC USES THEREOF | RHODIA CHIMIE SA (FR) | 1998-07-29 | — | — | EP | claimed |
| US-12037541-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2024-07-16 | — | — | US | disclosed |
| US-20220033705-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-02-03 | — | — | US | disclosed |
| US-11186764-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2021-11-30 | — | — | US | disclosed |
| US-20190330516-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-10-31 | — | — | US | disclosed |
| US-10400156-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-09-03 | — | — | US | disclosed |
| US-20170313928-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2017-11-02 | — | — | US | disclosed |
| CN-105642185-A | Anionic-cationic-nonionic surfactant, preparation method therefor and application of anionic-cationic-nonionic surfactant | 中国石油化工股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| US-5869712-A | α-amino-substituted acetic acids or acid salts and their use in cosmetics | RHONE-POULENC CHIMIE (FR) | 1999-02-09 | — | — | US | disclosed |
| EP-0472107-B1 | Cationic compound and cleaning composition | KAO CORP (JP) | 1994-12-14 | — | — | EP | disclosed |
| US-5318727-A | Reacting cyclic amidine and/or acyclic amideamine with cationizing quaternary amine compound | KAO CORPORATION (JP) | 1994-06-07 | — | — | US | disclosed |
| US-5162315-A | Topical administration of diltiazem | THERAPEUTIC PATCH RESEARCH N.V. | 1992-11-10 | — | — | US | disclosed |
| EP-0472107-A2 | Cationic compound and cleaning composition | KAO CORPORATION (JP) | 1992-02-26 | — | — | EP | disclosed |
| EP-0269940-B1 | SURFACE ACTIVE AGENT AND PROCESS FOR PREPARING THE SAME | Kao Corporation (JP) | 1991-12-04 | — | — | EP | disclosed |
| US-4885112-A | CONTAINING LOW PERCENTAGE OF INORGANIC SALT; COMPATIBILITY, STABILITY | KAO CORPORATION (JP) | 1989-12-05 | — | — | US | disclosed |
| US-4705893-A | IMIDAZOLINES | KAO CORPORATION (JP) | 1987-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330516-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | LIPA, ABHD12, ABHD16A | NAAA 94/4885SELP 635/4885FAAH 295/4885 |
| US-12037541-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, SGMS1, AQP1 | NAAA 108/4885SELP 998/4885FAAH 220/4885 |
| US-11186764-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, ABHD12, ABHD16A | NAAA 94/4885SELP 635/4885FAAH 295/4885 |
| US-20220033705-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | LIPA, ABHD16A, ABHD12 | NAAA 78/4885SELP 719/4885FAAH 258/4885 |
| US-10400156-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, ABHD12, ABHD16A | NAAA 94/4885SELP 635/4885FAAH 295/4885 |
| US-20170313928-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF | LIPA, ABHD12, ABHD16A | NAAA 94/4885SELP 635/4885FAAH 295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.